Ace Investor Ashish Kacholia picks up stake in this company. Do you own it?
Ace Investor Ashish Kacholia picks up stake in this company. Do you own it?

Ace Investor Ashish Kacholia picks up stake in this company. Do you own it?

In the past 5 trading days, the stock has witnessed heavy buying, rising more than 35 per cent

DSIJ Intelligence Article rating: 4.0

Ace investor Ashish Kacholia has been added as the name of proposed allottee, having an option of 12,28,070 shares to be issued, aggregating to approximate value of Rs 17.5 crore

Watch out for these penny stocks locked in the upper circuit on January 31
Watch out for these penny stocks locked in the upper circuit on January 31

Watch out for these penny stocks locked in the upper circuit on January 31

Also, investors are keeping tabs on the Adani Group saga, the upcoming Union budget in new Parliament building on Wednesday and global central bank meetings.

DSIJ Intelligence Article rating: 4.0

On January 30, the foreign portfolio investors (FPIs) turned out to be the net sellers of shares worth Rs 6,792.80 crore and the domestic institutional investors (DIIs) turned out the net buyers of shares worth 5,512.63 crore. 

Three of Adani Group stocks see circuit limit revised to 10 per cent!
Three of Adani Group stocks see circuit limit revised to 10 per cent!

Three of Adani Group stocks see circuit limit revised to 10 per cent!

On the daily chart, the Nifty formed a bullish candle with long lower shadow, indicating sharp recovery from the lower levels.

DSIJ Intelligence-3 Article rating: 4.2

Talking about stock specific action, Adani Group stocks were in limelight and some of the stocks from this group hit lower circuit limit and in view of high volatility seen in these stocks, BSE has decided to revise circuit limit of 10 stocks which includes three stocks of Adani Group.

Upper Circuit: This micro-cap pharma stock reported stellar Q3FY23 results!
Upper Circuit: This micro-cap pharma stock reported stellar Q3FY23 results!

Upper Circuit: This micro-cap pharma stock reported stellar Q3FY23 results!

In an aim to expand their product portfolio, the company is focusing on developing multiple manufacturing sites

DSIJ Intelligence Article rating: 3.7

They initiated contract manufacturing from three new locations this quarter and with this, they are currently manufacturing at nine locations across India

Penny Stocks: Stocks likely to be in focus tomorrow!
Penny Stocks: Stocks likely to be in focus tomorrow!

Penny Stocks: Stocks likely to be in focus tomorrow!

Mid-cap and Small-cap indices underperformed broader markets

DSIJ Intelligence Article rating: 4.3

On Monday, Indian equity markets staged a decent recovery in the second half of a highly volatile trading session.

Only Buyers: Following an agreement with a Reliance subsidiary, shares of this smallcap company surged over 150 per cent in just one month!
Only Buyers: Following an agreement with a Reliance subsidiary, shares of this smallcap company surged over 150 per cent in just one month!

Only Buyers: Following an agreement with a Reliance subsidiary, shares of this smallcap company surged over 150 per cent in just one month!

On an intraday basis on Monday, shares surged and locked at a 5 per cent upper circuit at Rs 325.35 per share on the BSE, setting a new 52-week high.

DSIJ Intelligence Article rating: 3.8

On an intraday basis on Monday, shares surged and locked at a 5 per cent upper circuit at Rs 325.35 per share on the BSE, setting a new 52-week high.  

RSS
First18331834183518361838184018411842Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR